Collagenous gastritis is a rare inflammatory condition in which abnormally thick bands of collagen build up just beneath the surface lining of the stomach, disrupting normal gastric function and often leading to chronic anemia, abdominal pain, or persistent diarrhea depending on the patient’s age. First described in 1989 in a teenage girl with recurrent stomach pain and bleeding, the disease has remained poorly understood, with fewer than a hundred well-documented cases in the English-language medical literature as of recent reviews. What makes collagenous gastritis particularly tricky is that it can look like several more common stomach problems on endoscopy and often requires biopsy-level examination to confirm.
What Happens in the Stomach Wall
In a healthy stomach, a thin layer of collagen sits beneath the surface cells, providing structural support. In collagenous gastritis, that layer thickens dramatically. The diagnostic threshold is a collagen band thicker than 10 micrometers, but measured bands vary enormously from patient to patient. One study examining a series of confirmed cases found a median collagen band thickness of about 50 micrometers, with the thickest measuring 225 micrometers, roughly twenty times the diagnostic cutoff.1PubMed Central. Collagenous gastritis: clinical features, histologic correlates and unanswered questions Alongside the collagen buildup, inflammatory cells accumulate in the surrounding tissue.2PubMed Central. Collagenous gastritis: Review
For years, the leading assumption was that something had gone wrong with collagen production itself. More recent research points in a different direction. Gene-expression studies of affected gastric tissue have identified a mixed inflammatory profile involving both major branches of the adaptive immune system, along with immune cells that specifically home to the gut lining. The emerging picture is one of immune dysregulation driving the collagen buildup rather than a defect in collagen-making cells themselves.3PubMed Central. Collagenous gastritis: current understanding of a rare immune-mediated gastropathy across pediatric and adult phenotypes-from pathogenesis to therapeutic strategies That shift in understanding matters because it opens the door to immune-targeted treatments rather than just managing symptoms.
How Symptoms Differ Between Children and Adults
Early case reports suggested that collagenous gastritis splits neatly into two forms: a pediatric version dominated by anemia and a bumpy-looking stomach lining, and an adult version dominated by watery diarrhea linked to collagenous colitis further down the digestive tract.4PubMed Central. Collagenous gastritis, a new spectrum of disease in pediatric patients: two case reports That two-subtype framework shaped clinical thinking for years, and it still shows up in many gastroenterology references. But the evidence is more blurred than that clean division implies.
A comparative study collecting 10 pediatric and 21 adult cases found that both groups shared similar rates of anemia, abdominal pain, and diarrhea. Half the children had anemia and half had abdominal pain; among adults, roughly a third had anemia and just under half had pain. Diarrhea appeared in about 40 percent of children and 55 percent of adults. The researchers concluded that no reliable clinical differences separated the two age groups.5PubMed. A Comparative Clinicopathologic Study of Collagenous Gastritis in Children and Adults: The Same Disorder With Associated Immune-mediated Diseases
Still, some patterns hold up better than others. In children, iron deficiency anemia tends to be the symptom that triggers investigation, and it can be severe enough to require transfusions. A large pediatric cohort study found that the most frequent presenting symptoms were abdominal pain (about 78 percent), vomiting (65 percent), anemia (58 percent), and nausea (56 percent), with diarrhea trailing at about a third of cases.6PubMed. Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort Girls appear to be affected more often than boys.7PubMed Central. Collagenous Gastritis: A Cause of Pediatric Iron Deficiency Anemia
In adults, the classic presentation described in older literature is chronic watery diarrhea, often because the same collagenous process affects the colon as well.8PubMed Central. Collagenous Gastritis a Rare Disorder in Search of a Disease But as more cases are identified and more carefully studied, the reality is that adult presentations can include pain, nausea, and anemia just as readily as diarrhea. The safest generalization is that any combination of chronic upper abdominal symptoms, unexplained anemia, or persistent diarrhea in the setting of unusual endoscopic findings should raise the possibility.
Getting to a Diagnosis
The challenge with collagenous gastritis is that nothing about the symptoms alone points to it. Iron deficiency anemia is extremely common, abdominal pain has hundreds of causes, and chronic diarrhea typically leads a clinician to think about conditions far more prevalent than this one. The path to diagnosis almost always runs through endoscopy followed by biopsy.
On endoscopy, the stomach lining often appears bumpy or nodular, sometimes with redness or erosion. But these findings are nonspecific and can mimic other conditions. The first reported case, back in 1989, showed persistent nodularity and redness of the stomach body in a 15-year-old girl with recurrent pain and gastrointestinal bleeding.2PubMed Central. Collagenous gastritis: Review That visual pattern, while suggestive, could also represent lymphocytic gastritis, chronic Helicobacter pylori infection, or Crohn’s disease of the stomach, among other diagnoses.
The definitive diagnosis comes from histology. A pathologist examining biopsy tissue looks for the characteristic thick collagen band beneath the surface cells. Special stains, particularly trichrome staining, highlight collagen and make the band easier to measure. The collagen must be thicker than the 10-micrometer cutoff, and inflammatory cells should be present in the tissue around it.2PubMed Central. Collagenous gastritis: Review Because the collagen deposits can be patchy rather than evenly distributed, multiple biopsies from different parts of the stomach improve the chances of catching it.
Conditions That Travel Alongside It
Collagenous gastritis rarely travels alone, and the company it keeps gives clues about its underlying nature. The most well-known overlap is with collagenous colitis, where the same collagen-thickening process occurs in the colon. When both conditions appear together, the diarrhea component tends to dominate the clinical picture.9PubMed Central. Concurrent Collagenous Gastritis and Collagenous Colitis: A Case Presentation and Review of the Literature This overlap has led some researchers to wonder whether the two conditions represent a single disease affecting different parts of the gut, while others view them as related but independent processes.
Autoimmune conditions show up frequently in patients with collagenous gastritis. Celiac disease is one of the best-documented associations, co-occurring in roughly a tenth of cases in one review, with variable severity and mixed responses to a gluten-free diet.1PubMed Central. Collagenous gastritis: clinical features, histologic correlates and unanswered questions The overlap with celiac disease can create diagnostic confusion, since both conditions may cause similar-looking damage in the upper small intestine.10PubMed Central. Atypical Presentations of Collagenous Gastritis Mimicking Celiac Sprue Other autoimmune conditions reported alongside collagenous gastritis include Sjögren syndrome, lymphocytic colitis, and Hashimoto’s thyroiditis.11American Journal of Gastroenterology. Collagenous Gastritis in a Patient With Hashimoto’s Thyroiditis: First Reported Case and Long-term Management
Helicobacter pylori infection has also been reported in about 10 percent of collagenous gastritis cases, and in several of those cases, treating the H. pylori infection led to partial or complete resolution of the collagenous gastritis features.1PubMed Central. Collagenous gastritis: clinical features, histologic correlates and unanswered questions Whether H. pylori actually triggers the collagen buildup in susceptible individuals or is merely a bystander remains an open question, but the treatment response in some patients suggests it could be a meaningful contributor.
Medication-Related Triggers
An underappreciated part of the diagnostic picture is that certain medications can cause gastric changes that mimic collagenous gastritis. Olmesartan, a blood pressure drug in the angiotensin receptor blocker class, has been linked to a pattern of stomach inflammation that includes increased collagen beneath the surface cells, gland damage, and lymphocyte infiltration. These findings can look indistinguishable from idiopathic collagenous gastritis on biopsy.12PubMed Central. Olmesartan-associated Gastritis Observed Over Time
The practical takeaway is that any patient diagnosed with collagenous gastritis should have their medication list scrutinized. If they are taking olmesartan or a related drug, stopping the medication and observing whether the gastritis improves is an important diagnostic and therapeutic step. A diagnosis of collagenous gastritis made while the patient is on olmesartan should be treated with some caution until a drug-related cause has been excluded.
Treatment Options
No randomized controlled trials have tested treatments for collagenous gastritis head-to-head, and given how rare the disease is, such trials may never happen.2PubMed Central. Collagenous gastritis: Review Everything known about treatment comes from case series and individual reports, so the evidence base is modest. That said, several approaches have shown consistent enough results to form a working treatment strategy.
Topical Budesonide
The best-studied treatment is topical budesonide, a steroid that is swallowed as a slurry or suspension so it coats the stomach lining directly rather than being absorbed systemically. In the largest treatment series published to date, about 89 percent of patients treated with topical budesonide had a clinical response, with roughly 42 percent achieving complete symptom resolution and 46 percent achieving partial improvement. Histologically, 88 percent showed improvement, with over half achieving complete resolution of the collagen thickening on biopsy.13PubMed. Collagenous Gastritis: Characteristics and Response to Topical Budesonide Those are encouraging numbers for a disease with so few treatment options. Because budesonide acts locally, it tends to cause fewer side effects than systemic steroids like prednisone, though long-term use still carries some concerns about steroid-related effects.
When Budesonide Falls Short
Not everyone responds to budesonide. For patients who do not improve, or who relapse when the drug is stopped, clinicians have turned to immune-targeted therapies. Vedolizumab, a biologic drug that blocks immune cells from migrating to the gut, has been used successfully in at least one well-documented case where topical budesonide had failed to produce clinical or endoscopic improvement. After intravenous vedolizumab infusions, the patient achieved meaningful clinical and pathologic improvement.14PubMed Central. Clinical and Pathologic Response to Vedolizumab in a Young Female Patient With Collagenous Gastritis The choice of vedolizumab makes biological sense given the finding that activated immune cells use gut-specific homing pathways to reach the stomach lining in this disease.3PubMed Central. Collagenous gastritis: current understanding of a rare immune-mediated gastropathy across pediatric and adult phenotypes-from pathogenesis to therapeutic strategies
Supportive Care
Regardless of the primary treatment strategy, managing the downstream effects of collagenous gastritis is essential. Iron supplementation is often necessary, particularly in pediatric patients where severe iron deficiency anemia can be the presenting problem. In cases where significant gland loss has occurred in the stomach body, acid suppression with proton pump inhibitors and monitoring for nutritional deficiencies become part of routine care. One reported case involved a woman with complete loss of the acid-producing glands in the stomach body who was treated with a proton pump inhibitor and iron supplementation.15PubMed Central. Collagenous Gastritis: An Atypical Presentation of a Rare Disease Severe gastric atrophy can also impair absorption of vitamin B12 and other nutrients, which may require monitoring and replacement over time.
Long-Term Outlook and the Question of Cancer Risk
Because collagenous gastritis is so rare and most published cases involve relatively short follow-up periods, the long-term natural history remains uncertain. The disease tends to be chronic, with symptoms waxing and waning over years. Some patients respond well to treatment and maintain remission; others have a more stubborn course.
One concern that has surfaced in long-term case reports is the theoretical risk of more serious changes in the stomach lining over time. The most detailed long-term follow-up comes from a single patient tracked over 12 years through 19 separate endoscopic procedures. Over that period, the patient developed progressive gland loss, overgrowth of hormone-producing cells in the stomach body, intestinal metaplasia (where stomach cells take on characteristics of intestinal cells), and changes that pathologists could not clearly classify as benign or precancerous.16Oxford Academic. Collagenous Gastritis: A Long-Term Follow-up With the Development of Endocrine Cell Hyperplasia, Intestinal Metaplasia, and Epithelial Changes Indeterminate for Dysplasia These findings raised concerns about the potential for eventual progression to adenocarcinoma or a neuroendocrine tumor.
It is worth noting that this is a single case, and generalizing from one patient to all patients with collagenous gastritis would be premature. No series has documented actual cancer developing from collagenous gastritis. But the theoretical risk is plausible enough that most gastroenterologists recommend ongoing surveillance with periodic endoscopy and biopsy for patients with long-standing disease, particularly those with significant glandular atrophy.
Why Diagnosis Often Takes So Long
Patients with collagenous gastritis frequently describe a frustrating journey to diagnosis, and there are good structural reasons for that. The symptoms overlap heavily with far more common conditions. A child with iron deficiency anemia is much more likely to have a dietary cause, heavy menstrual periods, or celiac disease than collagenous gastritis. An adult with chronic diarrhea is more likely to have irritable bowel syndrome, microscopic colitis, or celiac disease. The rarity of collagenous gastritis means it simply is not high on most clinicians’ differential diagnosis lists.
Even when endoscopy is performed, the visual findings can be misread. Nodularity in the stomach can be attributed to H. pylori infection, lymphocytic gastritis, or even normal variation. Without a pathologist who is specifically looking for subepithelial collagen thickening and uses appropriate stains, the biopsy can be read as nonspecific chronic gastritis. The overlap with celiac disease is another pitfall: some patients with collagenous gastritis have been initially diagnosed with celiac disease because of similar-appearing changes in the duodenum.10PubMed Central. Atypical Presentations of Collagenous Gastritis Mimicking Celiac Sprue Only when the patient does not respond to a gluten-free diet is the diagnosis revisited.
For patients with unexplained and persistent upper gastrointestinal symptoms, especially those with refractory iron deficiency anemia or symptoms that do not fit a common diagnosis, asking a gastroenterologist specifically about collagenous gastritis and ensuring that biopsies include special stains for collagen can be the difference between years of diagnostic limbo and a clear answer.
Living with a Rare Gastric Condition
Beyond the clinical details, collagenous gastritis carries the particular burden of rarity. Most general practitioners have never seen a case. Online patient communities are small. There is no disease-specific foundation or standardized treatment protocol. Patients often find themselves educating their own doctors about the condition, carrying copies of published case reports to appointments.
The nutritional consequences deserve attention in daily life. Chronic inflammation and gland loss in the stomach can impair the absorption of iron, vitamin B12, calcium, and potentially other micronutrients. Fatigue from anemia is often the symptom that affects quality of life more than the abdominal discomfort itself. For children, the growth implications of chronic nutritional deficiency can be significant, and regular monitoring of growth trajectories alongside nutritional markers is prudent. About a fifth of children in one cohort had poor growth, and a quarter experienced weight loss.6PubMed. Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort
Patients who respond to topical budesonide face the question of how long to stay on it. There is no consensus on duration, and some patients relapse when the medication is discontinued, suggesting that maintenance therapy may be needed. Others eventually taper off successfully. The lack of randomized data means these decisions are made case by case, often through trial and error, with repeated endoscopies to check whether the collagen deposits are resolving, stable, or worsening.